Bio-Reference Laboratories Inc  

(Public, NASDAQ:BRLI)   Watch this stock  
Find more results for BRLI
41.25
-0.01 (-0.02%)
Real-time:   12:39PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 40.89 - 41.76
52 week 26.32 - 46.74
Open 41.26
Vol / Avg. 506,955.00/916,875.00
Mkt cap 1.15B
P/E 22.71
Div/yield     -
EPS 1.82
Shares 27.80M
Beta 0.67
Inst. own 82%
Aug 25, 2015
Q3 2015 Bio-Reference Laboratories Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jul 10, 2015
Bio-Reference Laboratories Inc Annual Shareholders Meeting (Estimated) - 9:00AM EDT - Add to calendar
Jun 11, 2015
OPKO Health Inc Conference Call to Discuss Acquisition of Bio-Reference Laboratories Inc
Jun 9, 2015
Bio-Reference Laboratories Inc at William Blair Annual Growth Stock Conference
Jun 8, 2015
Q2 2015 Bio-Reference Laboratories Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Apr '15) 2014
Net profit margin 4.67% 5.62%
Operating margin 8.45% 10.02%
EBITD margin - 13.05%
Return on average assets 8.38% 10.39%
Return on average equity 12.67% 15.84%
Employees 3,406 -
CDP Score - -

Address

481 Edward H Ross Dr
ELMWOOD PARK, NJ 07407-3118
United States - Map
+1-201-7912186 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Bio-Reference Laboratories, Inc. is a clinical testing laboratory, which offers testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. The Company offers a range of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. It is focused on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional health care. It offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology and other tissue analysis. It operates a clinical knowledge management service through its PSIMedica business unit. It also operates a Web-based connectivity portal solution for laboratories and physicians through its CareEvolve subsidiary. Its laboratory testing business consists of routine testing and esoteric testing.

Officers and directors

Marc D. Grodman M.D. Chairman of the Board, President, Chief Executive Officer
Age: 63
Bio & Compensation  - Reuters
Nicholas Papazicos Chief Financial Officer
Age: 56
Bio & Compensation  - Reuters
Howard Dubinett Chief Operating Officer, Executive Vice President, Director
Age: 63
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Ilan Kaufthal Director
Age: 67
Bio & Compensation  - Reuters
Sam Singer Director
Age: 71
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joseph Benincasa Independent Director
Age: 65
Bio & Compensation  - Reuters
Harry Elias Independent Director
Age: 84
Bio & Compensation  - Reuters
John Roglieri M.D. Independent Director
Age: 75
Bio & Compensation  - Reuters